Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126105711 | 12610571 | 1 | I | 201506 | 20160712 | 20160801 | 20160801 | PER | US-ASTRAZENECA-2016SE76583 | ASTRAZENECA | 696.00 | MON | F | Y | 90.70000 | KG | 20160801 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126105711 | 12610571 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | 40 | MG | CAPSULE | QD | |||||||
| 126105711 | 12610571 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG OR 80 MG TWICE A DAY | 21153 | CAPSULE | |||||||||
| 126105711 | 12610571 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 21153 | 40 | MG | CAPSULE | QD | |||||||
| 126105711 | 12610571 | 4 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | GENERIC TEVA NEXIUM | 21153 | ||||||||||
| 126105711 | 12610571 | 5 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | ||||||||||
| 126105711 | 12610571 | 6 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 126105711 | 12610571 | 7 | C | GAVISCON | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126105711 | 12610571 | 1 | Reflux gastritis |
| 126105711 | 12610571 | 2 | Reflux gastritis |
| 126105711 | 12610571 | 3 | Reflux gastritis |
| 126105711 | 12610571 | 4 | Reflux gastritis |
| 126105711 | 12610571 | 5 | Reflux gastritis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126105711 | 12610571 | Blood creatinine increased | |
| 126105711 | 12610571 | Blood urea increased | |
| 126105711 | 12610571 | Dehydration | |
| 126105711 | 12610571 | Dyspepsia | |
| 126105711 | 12610571 | Gluten sensitivity | |
| 126105711 | 12610571 | Heart rate increased | |
| 126105711 | 12610571 | Hypertension | |
| 126105711 | 12610571 | Hypothyroidism | |
| 126105711 | 12610571 | Intentional product misuse | |
| 126105711 | 12610571 | Joint swelling | |
| 126105711 | 12610571 | Off label use | |
| 126105711 | 12610571 | Pyrexia | |
| 126105711 | 12610571 | Respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126105711 | 12610571 | 1 | 2001 | 2003 | 0 | |
| 126105711 | 12610571 | 3 | 2004 | 0 |